Skip to Content
Upcoming Events
Past Events
Mar 12 - Mar 14, 2023

Pierluigi Paracchi, CEO and Co-founder Genenta Science
Carlo Russo, CMO and Head of Development Genenta Science

Jan 11, 2023 at 5:00 PM PST

The Italian Trade Agency and the Consulate General of Italy in San Francisco organize a side-event on the occasion of the 41st annual J.P. Morgan Healthcare Conference.


Join us for an evening dedicated to networking and investment opportunities with top Italian pharma and biotech companies and discover why Italy is one of the world's greatest centers


Location: Italian Innovation Centre - INNOVIT, San Francisco at 710 Sansome Street, CA.
Innovit - Italian Innovation and Culture Hub is a one-of-a-kind space that is specific for global innovation and to weave the best of Italy together…from culture, business, technology, and science.


Moderator: Brad Loncar - Loncar investments

Speaker Pierluigi Paracchi – CEO and Co-founder Genenta Science

Dec 10 - Dec 13, 2022
New Orleans, Louisiana

Title: Reprogramming macrophages using autologous hematopoietic stem cells as immunotherapy for glioblastoma: TEM-GBM study (NCT03866109)
Type: Poster
Presenter: Prof. Fabio Ciceri, Head of Hematology and Bone Marrow Transplantation Unit – San Raffaele Hospital

Prof. Fabio Ciceri
Head of Hematology and Bone Marrow Transplantation Unit – San Raffaele Hospital
Nov 15, 2022 at 4:00 PM CET

The Event is promoted by Amcham’s Bowling Green Bull, an initiative to connect Italian companies, entrepreneurs and top managers aiming for international growth and expansion in their interactions with U.S. financial markets and investors. Special Guest Karen Snow, Senior Vice President, Head of U.S. Listings and Revenue, Pierluigi Paracchi, CEO and Co-founder Genenta, Claudio Erba, CEO and Co-founder Docebo, Mauro Carobene, Chief Business Officer Kaleyra

Nov 8 - Nov 12, 2022
Boston, MA and virtual

Title: Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment - (TEM-GBM)
Type: Poster
Presenter: CMO Carlo Russo
Time: November 10-11, 9:00 AM – 8.30 PM ET

Oct 11 - Oct 14, 2022
Edinburgh, UK and virtual

Title: Genetically-modified hematopoietic stem cells as a one-time, systemic treatment for non-hematologic disorders
Type: Oral
Presenter: Bernhard Gentner, SR-TIGET, Milan and Co-founder of Genenta
Time: October 12, 11:10 AM -1:15 PM BST